Awards & QUALIFICATIONS
- Fellow of the Royal College of Ophthalmologists, 2016
- MRC/Fight for Sight Clinical Research Training Fellowship, 2015
- Crombie Medal, Royal College of Ophthalmologists 2011
- BM BCh with Distinction, University of Oxford 2010
- MA (First Class), University of Cambridge 2007
- Swann Prize for Biology, Gonville & Caius College, Cambridge 2007
- Gridley Fund Research Award, University of Cambridge 2006
- HE Durham Research Award, University of Cambridge 2006
- Ian Gordon-Smith Prize for Medicine, Gonville & Caius College, Cambridge 2005
MA (Cantab) BM BCh FRCOphth
MRC / Fight for Sight Clinical Research Training Fellow
- Honorary Specialist Registrar, Moorfields Eye Hospital, London
Harry's background is in Clinical Ophthalmology as a Specialist Registrar within the North London/Moorfields Eye Hospital training rotation. Through joint funding from the Medical Research Council and Fight for Sight, Harry is currently working towards a DPhil under the supervision of Professor Robert MacLaren as part of a Clinical Research Training Fellowship at the University of Oxford.
Harry's research focusses on developing a new gene-therapy based treatment for dominant retinitis pigmentosa (RP) caused by defects in the rhodopsin gene. These mutations account for around a quarter of all cases of RP and are the most common genetic cause of sight loss in the UK.
Impact of Vital Dyes on Cell Viability and Transduction Efficiency of AAV Vectors Used in Retinal Gene Therapy Surgery: An In Vitro and In Vivo Analysis.
Salvetti AP. et al, (2017), Transl Vis Sci Technol, 6
Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina.
Patrício MI. et al, (2017), Mol Ther Nucleic Acids, 6, 198 - 208
Direct ophthalmoscopy should be taught within the context of its limitations.
Orlans HO., (2016), Eye (Lond), 30, 326 - 327
Dysthyroid Orbitopathy Presenting with Gaze-Evoked Amaurosis: Case Report and Review of the Literature.
Orlans HO. and Bremner FD., (2015), Orbit, 34, 324 - 326
Anti-VEGF Therapy and the Retina: An Update.
Tah V. et al, (2015), J Ophthalmol, 2015